Evidence map›Paper›PMID 29590614›Full record

ArticleCell reports2018

Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections.

Larissa B Thackray, Scott A Handley, Matthew J Gorman, Subhajit Poddar, Prachi Bagadia, Carlos G Briseño, Derek J Theisen, Qing Tan, Barry L Hykes, Hueylie Lin and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 138 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A single mutation in an enteric virus alters tropism and sensitivity to microbiota.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Larissa B ThackrayDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Scott A HandleyDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Matthew J GormanDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Subhajit PoddarDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Prachi BagadiaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Carlos G BriseñoDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Derek J TheisenDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Qing TanDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Barry L HykesDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Hueylie LinDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Tiffany M LucasDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Chandni DesaiDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Jeffrey I GordonCenter for Genome Sciences and Systems Biology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Kenneth M MurphyDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Howard Hughes Medical Institute, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, MO 63110, USA. Electronic address: diamond@wusm.wustl.edu.
Washington University in St. Louis · US

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LIVNY, MIRON · 2013 to 2017
$26.1M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
REGULATION OF GENE EXPRESSION - SMALL INTESTINER01DK030292 · NIDDK · WASHINGTON UNIVERSITY · PI JEFFREY I GORDON, ANDREI L OSTERMAN · 1986 to 2026
$6.5M
TAM Receptors and Virus InfectionR01AI101400 · NIAID · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI DIAMOND, MICHAEL S, KLEIN, ROBYN S. · 2012 to 2021
$5.8M
The enteric microbiome in treated and progressive HIV infectionR01DK101354 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KWON, DOUGLAS, VIRGIN, HERBERT W · 2014 to 2018
$3.7M
NIAID NIH HHS R01 AI101400NIAID NIH HHS T32 AI007163NIAID NIH HHS U19 AI106772NIAID NIH HHS U19 AI109725NIDDK NIH HHS R01 DK030292NIDDK NIH HHS R01 DK101354
6 · The paper itself

Abstract

Although the outcome of flavivirus infection can vary from asymptomatic to lethal, environmental factors modulating disease severity are poorly defined. Here, we observed increased susceptibility of mice to severe West Nile (WNV), Dengue, and Zika virus infections after treatment with oral antibiotics (Abx) that depleted the gut microbiota. Abx treatment impaired the development of optimal T cell responses, with decreased levels of WNV-specific CD8

Indexed as

Administration, OralAedesAmpicillinAnimalsAnti-Bacterial AgentsCecumChlorocebus aethiopsFemaleFlavivirusMaleMiceMice, Inbred C57BLMicrobiotaT-LymphocytesVero CellsZika Virus InfectionAmpicillinAnti-Bacterial AgentsDengue virusflavivirusgut microbiotaimmunityoral antibioticspathogenesis determinantsrisk factorsWest Nile virusZika virus

Identifiers

PMID29590614
PMCPMC5908250
OpenAlexW2795362564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.